RegentAtlantic Capital’s Allergan Inc AGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AGN
CA
ECM
HFS
AIM
RegentAtlantic Capital's AGN Position: Q1 2015 in Review
RegentAtlantic Capital sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 838 shares — an estimated $178K sold.
RegentAtlantic Capital first reported a position in AGN in Q4 2014 and held it in 1 quarter. The position peaked at $178K in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.
- RegentAtlantic Capital reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
- RegentAtlantic Capital sold 838 Allergan Inc shares in Q1 2015, an estimated $178K.
- RegentAtlantic Capital first reported a position in Allergan Inc in Q4 2014 and held it in 1 quarter.
- RegentAtlantic Capital's Allergan Inc position peaked at $178K in Q4 2014.
- 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.
Based on RegentAtlantic Capital's 13F filing for Q1 2015, filed 27 Apr 2015.